Ulcerative colitis (UC) is a chronic autoimmune disorder affecting the colonic mucosa. UC is
a subtype of inflammatory bowel disease along with Crohn's disease and presents with …

Clostridioides difficile is the most common cause of healthcare-associated diarrhea. Disease
complications as well as recurrent infections contribute significantly to morbidity and …

Helicobacter pylori is a highly prevalent bacteria that can harm humans due to its major
involvement in developing gastrointestinal diseases, particularly gastric cancer. Therefore …

Objectives Treatment guidelines are key drivers of prescribing practice in the management
of Clostridioides difficile Infection (CDI), but recommendations on best practice can vary. We …

Background Fecal microbiota transplantation (FMT) has shown excellent efficacy in treating
Clostridioides difficile infection, as well as promise in several other diseases. The …

Background Faecal microbiota transplantation (FMT) is increasingly being used in the
treatment of recurrent Clostridioides difficile infection (rCDI). Health economic evaluations …

Background Vulnerable patients with intestinal colonization of multidrug-resistant organisms
(MDROs) are recognized to be at increased risk of invasive MDRO-driven infection …

Vancomycin is the preferred treatment for Clostridioides difficile infection (CDI) but has been
associated with a high recurrence rate of CDI in treated patients. Fecal microbiota …

Clostridioides difficile infection (CDI) is an intestinal infection that causes morbidity and
mortality and places significant burden and cost on the healthcare system, especially in …

Background Compared to antibiotic treatment, fecal microbiota transplantation (FMT) is a
more effective treatment for refractory or recurrent CDI (rCDI). Patients with inflammatory …